Tenax Therapeutics, Inc. ( TENX) - Key Metrics
TENX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.35 | -$0.28 | -$0.28 |
| 2026Q1 | $0 | -$0.35 | -$0.21 | -$0.21 |
| 2025Q4 | $0 | -$0.40 | -$0.34 | -$0.34 |
| 2025Q3 | $0 | -$0.40 | -$0.23 | -$0.23 |
| 2025Q2 | $0 | -$0.27 | -$0.16 | -$0.16 |
TENX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.39 |
| 2026Q1 | 0% | -11.42 |
| 2025Q4 | 0% | -7.81 |
| 2025Q3 | 0% | -4.76 |
| 2025Q2 | 0% | -5.33 |
TENX
Price: $1.52
52 week price:
Earnings Per Share: -1.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 57000
Ebitda: -44.8 millionMarket Capitalization: 52.5 million